Creative Biolabs Provides Anti-CXCR4 Antibody for Research Use

SHIRLEY, NY - Sep 16, 2019 - September 16, 2019, Creative Biolabs, as a leading supplier in antibody production field, recently announced anti cxcr4 antibody and the related anti-cxcr4 dasatinib to assist researchers’ research projects. With the aim of offering high-quality and professional services and products for customers, scientists from Creative Biolabs contribute themselves to developing antibody items to meet different demands of clients and customers. The professional services from Creative Biolabs has convinced customers to use our items loyally. This announcement will be another big progress for Creative Biolabs.

Anti-CXCR4 antibody is a mouse monoclonal antibody, specifically binding to CXCR4, and this antibody can neutralize the bioactivity of CXCR4. It is usually recognized as the most useful in immunoassay techniques, including flow cytometry, neutralization, etc. CP-MAC-infected SUP-T1 human T cell lymphoblastic lymphoma line is its immunogen. Its high quality and professional processes can be guaranteed.

Dasatinib, alias DASA Tin IB, is a gray to yellow solid chemical. Salatinib is an anti-tumor drug, clinically mainly for the treatment of imatinib mesylate resistance, or intolerance of Philadelphia chromosome-positive chronic myeloid leukemia in chronic, accelerated and blast phase adult patients. The cd184 antibody from Creative Biolabs has proved a response in immunosuppressive drug treatment by a MOA of selectively delivering dasatinib to human T cells with excellent in vitro immunosuppressive activity. At the same time, the FDA has also approved dasatinib for the treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who are resistant or intolerant to other therapies through normal procedures.

“the anti-cxcr4 antibody and its related products has helped Creative Biolabs to gain a good fame from customers and the antibody field till now. With more than six months development, anti-cxcr4 antibody can be guaranteed with high quality its related professional services.” said Dr. Peterson, a senior scientist from R&D of Creative Biolabs.

“additionally, our scientists are continuing to develop more anti-cxcr4 antibody related products. It is believed that these products being developed will be influence the biology market in the near future. And at that time, Creative Biolabs is going to step on a new stage.” said Dr. Brown.

In addition to anti-cxcr4 dasatinib, Creative Biolabs has developed another related products, including anti-human CXCR4, recombinant human anti-cxcr4 antibody, etc. We do believe that Creative Biolabs can make big progress in antibody fields.

About Creative Biolabs

As an excellent supplier in antibody fields, Creative Biolabs is always holding the faith that providing the high-quality products and professional services to customers. Over the last 10 years, Creative Biolabs has contributed a lot in recombinant antibody (rAb) discovery and manufacturing fields. Besides, hybridoma development and phage display platforms from Creative Biolabs have helped more than 10 million researchers from academia and industry fields all over the world. all over the world. What’s more, a wide variety of diseases, such as immune disorders, cancers, infections are within our researches. It is believed that these products will contribute a lot to clinical researches and other lab use.